{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T02:21:43Z","timestamp":1765419703176,"version":"3.46.0"},"reference-count":7,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.annder.2025.103409","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:39:31Z","timestamp":1755823171000},"page":"103409","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Treatment of pemphigoid gestationis with omalizumab"],"prefix":"10.1016","volume":"152","author":[{"given":"E.","family":"Ribereau-Gayon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Donzier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Carbonnelle-Puscian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Le Roux-Villet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.-L.","family":"Breton-Guitarian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2025.103409_b0005","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jdin.2023.08.015","article-title":"Biologic therapy for refractory pemphigoid gestationis: an evidence-based systematic review","volume":"13","author":"Sood","year":"2023","journal-title":"JAAD Int"},{"key":"10.1016\/j.annder.2025.103409_b0010","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jaci.2019.05.019","article-title":"Pregnancy outcomes in the omalizumab pregnancy registry and a disease-matched comparator cohort","volume":"145","author":"Namazy","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.annder.2025.103409_b0015","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ijwd.2018.03.007","article-title":"Pemphigoid gestationis and intravenous immunoglobulin therapy","volume":"4","author":"Yang","year":"2018","journal-title":"Int J Womens Dermatol"},{"key":"10.1016\/j.annder.2025.103409_b0020","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/jdv.18227","article-title":"Successful treatment of recalcitrant pemphigoid gestationis with omalizumab: report of two cases","volume":"36","author":"Konstantinou","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2025.103409_b0025","first-page":"752","article-title":"Successful therapy of pemphigoid gestationis with dupilumab\u2014a new case","volume":"37","author":"Alvarez Martinez","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2025.103409_b0030","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/bjd\/ljad369","article-title":"Omalizumab in the treatment of bullous pemphigoid resistant to first-line therapy: a French national multicentre retrospective study of 100 patients","volume":"190","author":"Chebani","year":"2024","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2025.103409_b0035","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jri.2010.03.005","article-title":"Pregnant women have increased incidence of IgE autoantibodies reactive with the skin and placental antigen BP180 (type XVII collagen)","volume":"85","author":"Noe","year":"2010","journal-title":"J Reprod Immunol"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963825000687?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963825000687?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T02:18:18Z","timestamp":1765419498000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963825000687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":7,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0151963825000687"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2025.103409","relation":{},"ISSN":["0151-9638"],"issn-type":[{"type":"print","value":"0151-9638"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of pemphigoid gestationis with omalizumab","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2025.103409","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103409"}}